세계의 크론병 치료 시장 규모는 향후 수년간 강력한 성장이 예상되고 있으며, 2029년 176억 7,000만 달러에 달할 것으로 예측되며 CAGR 7.5%의 성장이 예상됩니다. 예측 기간의 성장은 맞춤형 의료 접근법, 생물 제제 시장 확대, 치료 지침의 진화, 의료비 증가, 공동 연구 활동으로 인한 것으로 예상됩니다. 예측 기간의 주요 동향은 환자 관리를 위한 원격 의료, 면역조절 전략 연구, 환자 중심 케어 모델, 디지털 건강 솔루션 통합 등입니다.
염증성 장 질환의 유병률 상승은 크론병 치료 시장의 성장을 가속할 것으로 예측됩니다. 염증성 장 질환은 소화관의 염증을 특징으로 하는 만성 질환군을 포함하며, 입에서 항문까지 소화기계의 모든 부분에 영향을 미칠 수 있습니다. 크론병의 치료는 장의 염증을 억제하고, 증상의 급성 악화를 예방하고, 관해를 유지하는 것을 목표로합니다. 예를 들어 2023년 9월, National Center for Biotechnology Information은 크론병과 궤양성 대장염의 유병률 상승을 보고하고 있으며, 염증성 장 질환은 2023년에 인구 10만명당 825명(크론병은 410명, 궤양성 대장염과 IBDU는 414명). 그 결과, 이러한 질병 증가 추세가 크론병 치료 시장의 성장에 기여하고 있습니다.
노화의 진행은 크론병 치료 시장의 확대를 촉진할 것으로 예측됩니다. 노인 비율 증가를 특징으로 하는 이 인구 역학의 변화는 크론병을 포함한 만성 질환의 유병률 증가에 기여하여 치료에 대한 수요를 증가시킵니다. 예를 들어 미국의 비영리 단체인 Population Reference Bureau(PRB)는 2024년 1월, 65세 이상의 미국인 수가 2022년 5,800만명에서 2050년까지 8,200만명으로 47% 증가할 것으로 예측했습니다. 이 연령대가 인구에서 차지하는 비율은 17%에서 23%로 증가할 것으로 예측됩니다. 이와 같이 노화의 확대가 크론병 치료 시장을 뒷받침하고 있습니다.
이 보고서는 전 세계 크론 병 치료 시장에 대한 조사 및 분석, 시장 특징, 시장 동향 및 전략, 각 지역 분석, 경쟁 구도 등에 대한 정보를 제공합니다.
목차
제1장 주요 요약
제2장 크론병 치료 시장 특징
제3장 크론병 치료 시장 동향과 전략
제4장 크론병 치료 시장 - 시장에 대한 금리, 인플레이션, 지정학, COVID와 회복의 영향을 포함한 거시경제 시나리오
제5장 세계의 크론병 치료의 성장 분석, 전략적 분석 프레임워크
- 세계의 크론병 치료의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업의 분석
- 세계 크론병 치료 시장의 성장률 분석
- 세계 크론병 치료 시장 규모와 성장 실적(2019-2024년)
- 세계 크론병 치료 시장 규모와 성장의 예측(2024-2029년·2034년)
- 세계 크론병 치료의 총 시장 규모(TAM)
제6장 크론병 치료 시장의 세분화
- 세계의 크론병 치료 시장 : 약제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 항생제
- 아미노살리실산
- 코르티코스테로이드
- 면역조절제
- 기타 약제 유형
- 세계의 크론병 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 크론병 치료 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 신경장애성 통증
- 섬유근통증
- 만성 요통
- 관절염 통증
- 편두통술 후 통증
- 암 통증
- 기타 용도
- 세계의 크론병 치료 시장, 항생 물질의 서브 세분화: 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 메트로니다졸
- 시프로플록사신
- 기타 항생제
- 세계의 크론병 치료 시장, 아미노살리실산염의 서브 세분화: 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 메살라민
- 술파살라진
- 기타 아미노살리실산염
- 세계의 크론병 치료 시장, 코르티코스테로이드의 서브 세분화: 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 프레드니손
- 부데소니드
- 기타 코르티코스테로이드
- 세계의 크론병 치료 시장, 면역 조절제의 서브 세분화: 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 아자티오프린
- 메토트렉세이트
- 메르캅토푸딩
- 세계의 크론병 치료 시장, 기타 약제 유형의 서브 세분화: 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 생물학적 제형
- 저분자
- 기타 치료
제7장 크론병 치료 시장의 지역과 국가 분석
- 세계의 크론병 치료 시장 :지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 크론병 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 크론병 치료 시장
제9장 중국의 크론병 치료 시장
제10장 인도의 크론병 치료 시장
제11장 일본의 크론병 치료 시장
제12장 호주 크론병 치료 시장
제13장 인도네시아 크론병 치료 시장
제14장 한국의 크론병 치료 시장
제15장 서유럽의 크론병 치료 시장
제16장 영국 크론병 치료 시장
제17장 독일 크론병 치료 시장
제18장 프랑스의 크론병 치료 시장
제19장 이탈리아의 크론병 치료 시장
제20장 스페인 크론병 치료 시장
제21장 동유럽의 크론병 치료 시장
제22장 러시아 크론병 치료 시장
제23장 북미의 크론병 치료 시장
제24장 미국의 크론병 치료 시장
제25장 캐나다 크론병 치료 시장
제26장 남미의 크론병 치료 시장
제27장 브라질 크론병 치료 시장
제28장 중동의 크론병 치료 시장
제29장 아프리카 크론병 치료 시장
제30장 크론병 치료 시장 경쟁 구도와 기업 프로파일
- 크론병 치료 시장 경쟁 구도
- 크론병 치료 시장 기업 프로파일
- AbbVie Inc.
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- Janssen Pharmaceuticals
제31장 크론병 치료 시장의 다른 주요 기업과 혁신적 기업
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Bristol-Myers Squibb Company
- Galapagos NV
- Novartis AG
- Sanofi SA
- F. Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd.
- Merck & Co. Inc.
- Mylan NV
- Glenmark Pharmaceuticals
- Tillotts Pharma AG
- Dr. Falk Pharma GmbH
- Shire Pharmaceuticals
제32장 세계의 크론병 치료 시장의 경쟁 벤치마킹과 대시보드
제33장 크론병 치료 시장에서의 주요 인수합병(M&A)
제34장 크론병 치료 시장의 최근 발전
제35장 크론병 치료 시장의 잠재성이 높은 국가, 부문, 전략
- 크론병 치료 시장 - 가장 새로운 기회를 제공하는 국가(2029년)
- 크론병 치료 시장 - 가장 새로운 기회를 제공하는 부문(2029년)
- 크론병 치료 시장 - 성장 전략(2029년)
제36장 부록
JHS
Crohn's disease treatment encompasses medical interventions and therapies designed to manage Crohn's disease, a chronic gastrointestinal condition. The primary goals of treatment are to mitigate inflammation in the intestines, prevent symptom flare-ups, and sustain overall recovery.
The key drug categories in Crohn's disease treatment include antibiotics, aminosalicylates, corticosteroids, immunomodulators, and others. Antibiotics are pharmaceuticals utilized for both treating and preventing bacterial infections. These drugs are accessible through diverse channels, including hospital pharmacies, retail pharmacies, and online pharmacies. They find applications in various medical conditions such as neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, migraine, post-operative pain, cancer pain, and other therapeutic areas.
The Crohn's disease treatment market research report is one of a series of new reports from The Business Research Company that provides Crohn's disease treatment market statistics, including Crohn's disease treatment industry global market size, regional shares, competitors with a Crohn's disease treatment market share, detailed Crohn's disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Crohn's disease treatment industry. This Crohn's disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The crohn's disease treatment market size has grown strongly in recent years. It will grow from$12.45 billion in 2024 to $13.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increased disease prevalence, advancements in diagnostic techniques, biological therapies adoption, patient awareness and education, clinical research and development
The crohn's disease treatment market size is expected to see strong growth in the next few years. It will grow to $17.67 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to personalized medicine approaches, biologics market expansion, evolving treatment guidelines, increased healthcare spending, collaborative research efforts. Major trends in the forecast period include telemedicine for patient management, research on immune modulation strategies, patient-centric care models, integration of digital health solutions.
The rising prevalence of inflammatory bowel disorders is expected to drive growth in the Crohn's disease treatment market. Inflammatory bowel disorders include a group of chronic conditions characterized by inflammation in the gastrointestinal tract, which can affect any part of the digestive system, from the mouth to the anus. Treatments for Crohn's disease aim to reduce intestinal inflammation, prevent symptom flare-ups, and maintain remission. For example, in September 2023, the National Center for Biotechnology Information reported a rise in the prevalence of Crohn's disease and ulcerative colitis, with inflammatory bowel disease projected at 825 cases per 100,000 people in 2023-410 for Crohn's disease and 414 for ulcerative colitis and IBD-unclassified. Consequently, the increasing occurrence of these disorders is contributing to the growth of the Crohn's disease treatment market.
The growing aging population is anticipated to drive the expansion of the Crohn's disease treatment market. This demographic shift, characterized by an increasing proportion of elderly individuals, contributes to a higher prevalence of chronic conditions, including Crohn's disease, thereby raising the demand for treatments. For example, in January 2024, the Population Reference Bureau (PRB), a U.S.-based nonprofit, projected that the number of Americans aged 65 and older would increase from 58 million in 2022 to 82 million by 2050, a 47% rise. This age group's share of the population is expected to grow from 17% to 23%. Thus, the expanding aging population is boosting the Crohn's disease treatment market.
Leading companies in the Crohn's disease treatment market are advancing drug innovation and securing approvals, including for biosimilars like ustekinumab, to provide more effective and accessible treatment options that enhance patient outcomes and quality of life. Biosimilar ustekinumab is a biologic closely matching the original ustekinumab (a monoclonal antibody) used for autoimmune conditions. For instance, in July 2024, Switzerland-based Sandoz International GmbH launched Pyzchiva (ustekinumab) across Europe, making it the first ustekinumab biosimilar available in all strengths, including a 130 mg vial for Crohn's disease. This treatment is approved for adults and children over six with plaque psoriasis, psoriatic arthritis, and Crohn's disease, expanding Sandoz's immunology portfolio and enhancing access to affordable treatments for chronic inflammatory diseases.
Major companies in the Crohn's disease treatment market are directing efforts toward the development of new treatment options, including oral medications for moderate-severe Crohn's disease. In March 2022, AbbVie Inc. announced FDA approval for RINVOQ (upadacitinib), the first once-daily oral medication for patients with moderate-to-severe Crohn's disease. This selective Janus kinase (JAK) inhibitor precisely targets inflammation pathways, offering a potential reduction in adverse events linked to immunosuppression.
In March 2022, Pfizer Inc., a prominent US-based biopharmaceutical company, completed the acquisition of Arena Pharmaceuticals Inc. for approximately $6.7 billion. This strategic acquisition aimed to expand Pfizer's inflammation and immunology therapeutic area pipeline portfolio, encompassing conditions such as atopic dermatitis, eosinophilic esophagitis, ulcerative colitis, and Crohn's disease. Arena Pharmaceuticals Inc., a US-based biopharmaceutical company, significantly contributes to Pfizer's presence and offerings in the Crohn's disease treatment market.
Major companies operating in the crohn's disease treatment market include AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.
North America was the largest region in the global Crohn's disease treatment market in 2024, and is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The crohn's disease treatment market consists of sales of vedolizumab, methotrexate, and infliximab. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Crohn's Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on crohn's disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for crohn's disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The crohn's disease treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Antibiotics; Amino Salicylates; Corticosteroids; Immunomodulators; Other Drug Types
- 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- 3) By Application: Neuropathic Pain; Fibromyalgia; Chronic Back Pain; Arthritic Pain; Migraine Post-Operative Pain; Cancer Pain; Other Applications
- Subsegments:
- 1) By Antibiotics: Metronidazole; Ciprofloxacin; Other Antibiotics
- 2) By Amino Salicylates: Mesalamine; Sulfasalazine; Other Amino Salicylates
- 3) By Corticosteroids: Prednisone; Budesonide; Other Corticosteroids
- 4) By Immunomodulators: Azathioprine; Methotrexate; Mercaptopurine
- 5) By Other Drug Types: Biologics; Small Molecules; Other Treatments
- Companies Mentioned: AbbVie Inc.; AstraZeneca plc; Boehringer Ingelheim GmbH; Eli Lilly and Company; Janssen Pharmaceuticals
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Crohn's Disease Treatment Market Characteristics
3. Crohn's Disease Treatment Market Trends And Strategies
4. Crohn's Disease Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Crohn's Disease Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Crohn's Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Crohn's Disease Treatment Market Growth Rate Analysis
- 5.4. Global Crohn's Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Crohn's Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Crohn's Disease Treatment Total Addressable Market (TAM)
6. Crohn's Disease Treatment Market Segmentation
- 6.1. Global Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antibiotics
- Amino Salicylates
- Corticosteroids
- Immunomodulators
- Other Drug Types
- 6.2. Global Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.3. Global Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neuropathic Pain
- Fibromyalgia
- Chronic Back Pain
- Arthritic Pain
- Migraine Post-Operative Pain
- Cancer Pain
- Other Applications
- 6.4. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Metronidazole
- Ciprofloxacin
- Other Antibiotics
- 6.5. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Amino Salicylates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mesalamine
- Sulfasalazine
- Other Amino Salicylates
- 6.6. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prednisone
- Budesonide
- Other Corticosteroids
- 6.7. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Azathioprine
- Methotrexate
- Mercaptopurine
- 6.8. Global Crohn's Disease Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biologics
- Small Molecules
- Other Treatments
7. Crohn's Disease Treatment Market Regional And Country Analysis
- 7.1. Global Crohn's Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Crohn's Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Crohn's Disease Treatment Market
- 8.1. Asia-Pacific Crohn's Disease Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Crohn's Disease Treatment Market
- 9.1. China Crohn's Disease Treatment Market Overview
- 9.2. China Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Crohn's Disease Treatment Market
- 10.1. India Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Crohn's Disease Treatment Market
- 11.1. Japan Crohn's Disease Treatment Market Overview
- 11.2. Japan Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Crohn's Disease Treatment Market
- 12.1. Australia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Crohn's Disease Treatment Market
- 13.1. Indonesia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Crohn's Disease Treatment Market
- 14.1. South Korea Crohn's Disease Treatment Market Overview
- 14.2. South Korea Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Crohn's Disease Treatment Market
- 15.1. Western Europe Crohn's Disease Treatment Market Overview
- 15.2. Western Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Crohn's Disease Treatment Market
- 16.1. UK Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Crohn's Disease Treatment Market
- 17.1. Germany Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Crohn's Disease Treatment Market
- 18.1. France Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Crohn's Disease Treatment Market
- 19.1. Italy Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Crohn's Disease Treatment Market
- 20.1. Spain Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Crohn's Disease Treatment Market
- 21.1. Eastern Europe Crohn's Disease Treatment Market Overview
- 21.2. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Crohn's Disease Treatment Market
- 22.1. Russia Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Crohn's Disease Treatment Market
- 23.1. North America Crohn's Disease Treatment Market Overview
- 23.2. North America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Crohn's Disease Treatment Market
- 24.1. USA Crohn's Disease Treatment Market Overview
- 24.2. USA Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Crohn's Disease Treatment Market
- 25.1. Canada Crohn's Disease Treatment Market Overview
- 25.2. Canada Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Crohn's Disease Treatment Market
- 26.1. South America Crohn's Disease Treatment Market Overview
- 26.2. South America Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Crohn's Disease Treatment Market
- 27.1. Brazil Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Crohn's Disease Treatment Market
- 28.1. Middle East Crohn's Disease Treatment Market Overview
- 28.2. Middle East Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Crohn's Disease Treatment Market
- 29.1. Africa Crohn's Disease Treatment Market Overview
- 29.2. Africa Crohn's Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Crohn's Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Crohn's Disease Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Crohn's Disease Treatment Market Competitive Landscape And Company Profiles
- 30.1. Crohn's Disease Treatment Market Competitive Landscape
- 30.2. Crohn's Disease Treatment Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Janssen Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
31. Crohn's Disease Treatment Market Other Major And Innovative Companies
- 31.1. Pfizer Inc.
- 31.2. Takeda Pharmaceutical Company Limited
- 31.3. Biogen Inc.
- 31.4. Bristol-Myers Squibb Company
- 31.5. Galapagos NV
- 31.6. Novartis AG
- 31.7. Sanofi S.A.
- 31.8. F. Hoffmann-La Roche Ltd.
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Merck & Co. Inc.
- 31.11. Mylan N.V.
- 31.12. Glenmark Pharmaceuticals
- 31.13. Tillotts Pharma AG
- 31.14. Dr. Falk Pharma GmbH
- 31.15. Shire Pharmaceuticals
32. Global Crohn's Disease Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Crohn's Disease Treatment Market
34. Recent Developments In The Crohn's Disease Treatment Market
35. Crohn's Disease Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Crohn's Disease Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Crohn's Disease Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Crohn's Disease Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
